What Is Metabolic Syndrome?

Given these facts, this research paper will address this question. I will examine the effects of schizophrenia upon adults in the US. I have presented an overview of schizophrenia, the discovery of the illness. I will explain how genetics intertwined with schizophrenia. To fully explore the topic this paper will discuss the following questions.

The prevalence of schizophrenia is thought to be about 1% of the population around the world. The disorder is considered to be one of the top ten causes of long-term disability worldwide. Late adolescence and early adulthood are periods for the onset of schizophrenia. In 40% of men and 23% of women diagnosed with schizophrenia, the condition manifested before the age of 19 (Addington, Cadenhead, Cannon, 2007).These are critical years in a young adult’s social and vocational development.

Although schizophrenia may come off as an interesting and unique disorder, it also relates to the Emotional, Social, and Intellectual dimensions of Health and Wellness. Schizophrenia is an disorder that affects a person’s ability to think, feel and behave clearly. The emotional dimension of the wellness wheel is described as the ability to understand ourselves and cope with the challenges life can bring. Also, the ability to acknowledge and share feelings of fear, sadness or stress; hope, love, joy and happiness in a productive manner contributes to our emotional wellness. This connects to schizophrenia because when you have this disorder it perceives you to imagine situations that aren’t actually happening. Usually people diagnosed with this

Metabolic syndrome is the umbrella term used for a variety of risk factors that increases the risk of heart disease and other health problems. Five conditions that are metabolic risk factors are: high Body Mass Index, insulin resistance, low HDL cholesterol, high blood pressure, and high fasting blood sugar. Obesity, an example of a metabolic disorder, has been the focus of research and medical discussions because of the alarming impacts that it is having on the health of millions of citizens in the United States. According to the Center of Disease Control and Prevention growth charts, last year 17% of children in America from age 2-9 were obese and 32% were overweight (Blumberg, 559). As a result, obesity costs the U.S. healthcare more than $200 billion and these costs will continue to increase as the number of obese individuals escalates (Janesick 2016, 559).

Despite the advances of antipsychotic medications, schizophrenia is a leading cause of global disability associated with high rates of hospitalizations, depression, and suicide attempts (Statistics Canada, 2015, para. 5). According to the National Institute of Mental Health (NIMH) (2016), “schizophrenia is a chronic and severe mental disorder that affects how a person thinks, feels, and behaves” (para. 1). Additionally, individuals with schizophrenia may experience varied symptoms including: delusions and hallucinations; movement and thought disorders; flat affect and decreased pleasure; and impaired attention and memory (NIMH, 2016, para. 4, 5, 6). The purpose of this paper is to examine the impacts of nonpharmacological interventions in the population of adults with schizophrenia. Several modalities of nonpharmacological treatments have been examined for efficacy, however our research focuses specifically on the following categories: (a) psychoeducation and cognitive behavioural therapy (CBT), (b) physical fitness and yoga programs, (c) combined pharmacological and nonpharmacological therapies, (d) case management and community services, and (e) technology and relational agents.

Many individuals in United States have been diagnosed with a mental disorder of some type. According to the National Institute of Mental Health (NIMH) about 1% of the American people have been diagnosed with the devastating mental disorder called schizophrenia. Schizophrenia is a severe mental illness that deeply affects the everyday life of not only the patient but their family and friends as well. Although there are many people who suffer from this demoralizing mental illness, experts say one thing they are sure on is that there’s a lot they don’t know about the disorder.

Metabolic syndrome is an emerging diagnosis in the medical field that has effects on patient care. Becoming familiar with it and having it become a common part of patient care will, if used appropriately will increase the lives of those who have become affected with or are at risk of becoming diagnosed with metabolic syndrome. Metabolic syndrome is a constellation of risks factors of metabolic origin that are accompanied by the increased risk of cardiovascular disease and type 2 diabetes. There are five major factors to look for; out of these five a person only needs three to be diagnosis with metabolic

Schizophrenia is a life-long disorder that affects about one percent of the population (Mueser & McGurk, 2004). The cause of this mental illness is still unclear. Studies have suggested that Schizophrenia does not arise from one factor but from a combination of genetic, environmental, and social factors (Liddle, 1987). People diagnosed with Schizophrenia struggle to deal with a multitude of symptoms that make it difficult to function (Mueser & McGurk, 2004). Antipsychotic medications are a popular treatment of the symptoms of Schizophrenia (Mueser & McGurk, 2004). Research is constantly being done to develop these medications to enhance the quality of life of those diagnosed with Schizophrenia.

Schizophrenia is a psychiatric disorder that is characterized by a variety of symptoms and the disorganization of feeling and thought. It is an incurable disease whose causes are unknown, yet whose effects are mind and body crippling. (Young, 1988, p.13-14) This topic was chosen because it is interesting to study a disorder that worldwide, is viewed as a classic example of madness and insanity. Another reason of interest is because unlike many illnesses, schizophrenia doesn't have a noticeable pattern and its difficulty to be diagnosed as a disease makes the collection of statistics difficult. It is important to learn more about schizophrenia because a significant numbr of people are affected everyday

Approximately 22% of the American population suffers from some kind of mental disorder at any given time. (Passer and Smith, 2004) Schizophrenia is one of the most serious of these mental disorders, and there are many different kinds of treatment. While all mental disorders offer diagnosis and treatment challenges, few are more challenging than schizophrenia. It is both bizarre and puzzling, and has been described as “one of the most challenging disorders to treat effectively.” (Passer and Smith, 2004, 534)

This all male based study consisted of 3210 individuals of whom were born between October 1959 and December 1961. Cases of schizophrenia came to surface during the year of 1999 and were noted in the Danish Psychiatric Central Register. The cases involving the individuals who developed the disorder were considered the experimental group of which were then compared to the control group. The control group involved factors of height, weight, and BMI from draft records in relation to those factors from the experimental group. The average age of the participants of the study were about 19.2 years. Identification of parental hospitalization history was gathered in relation to specific diagnosis '. Strong evidence supports the association of adult BMI with schizophrenia and how it differs in subjects with and without family history of this mental illness. To be considered schizophrenic in medical terms would involve being diagnosed according to codes, these codes include code 295 and code F20 or ICD-8/ ICD-10. (Sorensen, Mortensen, Reininsch, Mednick, 2006, Pg.3) The independent variable for this experiment would be the height, weight, and BMI draft records where as the dependent variable would be the

“A major concern at this time is the rapid climb in incidence of Type 2 diabetes, with prevalence now estimated at about 9% (18 million) of the population greater than 20 years of age.” Obesity and Type 2 diabetes are commonly associated (Gould & Dyer, 2011). In addition to the two types of diabetes, there are signs and symptoms that are easily detected and some that develop after diagnosis.

Approximately 1 percent of the world’s population is affected by schizophrenia. This illness does not discriminate. The symptoms usually start between ages 16 and 30. Once an individual reaches the age of 45, it is rare that schizophrenia manifests. Schizophrenia seldom occurs in children; however, awareness of childhood-onset schizophrenia is increasing (The National Institute of Mental Health, 2009). The symptoms tend to effect men more severely than women and those who suffer from schizophrenia are known to have a higher risk of substance abuse and suicide rates. Approximately 10 percent of the schizophrenia communities commit suicide. The most common addiction shared by these individual is (The National Institute of Mental Health, 2009).

The diagnostic criteria for the MetS (metabolic syndrome) was established in 1998 by WHO (World Health Organization), in 2001 by NCEP: ATP III (National Cholesterol Education Program’s Adult Treatment Panel III) and in 2005 by IDF (International Diabetes Federation).

According to Krause’s Food & the Nutrition Care Process (2011), one primary health risk involved with untreated morbid obesity is metabolic syndrome, which tends to occur with the progression of excessive visceral adipose tissue and low cardiorespiratory fitness.1 Mr. McKinley’s BMI classifies him as morbidly obese, and he works as an office manager and has had a total knee replacement, which may contribute to physical inactivity and therefore increases metabolic syndrome risk. Since Mr. McKinley has elevated triglycerides (245 mg/dL) and fasting glucose (145 mg/dL), and lowered high-density lipoprotein (HDL) levels (32 mg/dL), he meets the criteria for metabolic syndrome. The presence of